Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00008372 · ClinicalTrials.gov registry record · Phase 2
Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer
A Phase 2 study of Lung Cancer, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Study locations
NCT00008372: Completed Phase 2 study of Lung Cancer, sponsored by City of Hope Medical Center.
NCT00008372 is a Phase 2 study of Lung Cancer that has completed, run by City of Hope Medical Center. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00008372, a Phase 2 study of Lung Cancer, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3
- Study locations
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have small cell lung cancer that has not responded to platinum-based chemotherapy.
Conditions Studied
Interventions
- DRUG chloroquinoxaline sulfonamide
Study Locations (3)
California
- Cancer Center and Beckman Research Institute, City of Hope - Duarte
- USC/Norris Comprehensive Cancer Center and Hospital - Los Angeles
- University of California Davis Cancer Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-12 |
| Est. Completion | 2002-09 |
| Phase | Phase 2 |
What the finished NCT00008372 record still lists
NCT00008372 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which chloroquinoxaline sulfonamide is the first listed.
NCT00008372 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00008372 about?
NCT00008372 is a clinical study titled "Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have small cell lung cancer that has not responded to platinum-based c...
What is the current status of trial NCT00008372?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-12. Estimated completion is 2002-09.
What conditions does trial NCT00008372 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT00008372?
The interventions under investigation include: chloroquinoxaline sulfonamide (DRUG).
Who is sponsoring clinical trial NCT00008372?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00008372 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Novel Treatment Combinations in Patients With Lung Cancer
RECRUITING · Phase 2
-
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
RECRUITING · Phase 2
-
ATATcH Alternating Treatment Plans for Advanced Cancer
RECRUITING · Phase 2
-
A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia